Human Infertility

Intrexon through collaboration utilizes its synthetic biology technologies to develop methodologies for enabling accelerated and scalable development of next-generation approaches to in vitro fertilization. Importantly, this work may provide new treatment options for women with compromised eggs, or who may be unwilling or unable to undergo hormone hyperstimulation, such as women diagnosed with cancer who seek to preserve their future fertility.